CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jan. 31, 2026	Jan. 25, 2025
Operating activities
Net (loss) income	$ (328,296,000)	$ 26,955,000
Adjustments to reconcile net (loss) income to cash used in operating activities:
Depreciation and amortization	202,960,000	27,144,000
Impairment of goodwill	240,708,000
(Gain)/Loss from equity method investments	(2,688,000)	(1,055,000)
Amortization of debt issuance costs	10,273,000	1,121,000
Provision for credit losses	1,867,000	(64,000)
Reserve for inventory excess and obsolescence	5,125,000	2,025,000
Other non-cash expense, net	3,543,000	1,810,000
Non-cash lease expense	18,889,000	7,379,000
Loss on foreign currency transactions	264,000	(22,000)
Unrealized gain on available-for-sale equity securities, net	(7,446,000)	(1,187,000)
Deferred income taxes	(6,464,000)
Stock-based compensation	28,065,000	15,518,000
Loss on disposal of property and equipment	1,149,000	201,000
Amortization of debt securities	(661,000)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(19,892,000)	(11,095,000)
Unbilled receivables and retentions	(142,088,000)	(30,172,000)
Inventories	(92,721,000)	(1,167,000)
Income taxes receivable	(38,646,000)	(14,738,000)
Prepaid expenses and other assets	(13,287,000)	(9,314,000)
Accounts payable	(17,397,000)	(1,359,000)
Other liabilities	(17,174,000)	(13,034,000)
Net cash (used in) provided by operating activities	(173,917,000)	(1,054,000)
Investing activities
Acquisition of property and equipment	(46,134,000)	(14,292,000)
Contributions in equity method investments	(3,243,000)	(2,309,000)
Purchase of available-for-sale investments	(335,183,000)
Redemption of available-for-sale investments	21,500,000
Acquisition of capitalized software to be sold	(17,275,000)
Business acquisitions, net of cash acquired	(844,586,000)
Net cash used in investing activities	(1,224,921,000)	(16,601,000)
Financing activities
Principal payments of revolver	(265,000,000)
Proceeds from shares issued, net of underwriter costs	968,515,000
Proceeds from convertible debt, net of underwriter costs	726,944,000
Payment of debt issuance costs	(2,445,000)	(1,056,000)
Payment of equity issuance costs	(1,388,000)	(365,000)
Holdback and retention payments for business acquisition		(390,000)
Tax withholding payment related to net settlement of equity awards	(10,900,000)	(4,064,000)
Employee stock purchase plan contributions	4,355,000
Exercise of stock options		506,000
Other	(12,000)	(19,000)
Net cash provided by (used in) financing activities	1,647,210,000	(8,388,000)
Effects of currency translation on cash and cash equivalents	644,000	(258,000)
Net increase (decrease) in cash and cash equivalents	249,016,000	(26,301,000)
Cash and cash equivalents at beginning of period	40,862,000	73,301,000
Cash and cash equivalents at end of period	289,878,000	47,000,000
Cash paid, net during the period for:
Income taxes	4,335,000	19,342,000
Interest	12,535,000	1,196,000
Non-cash activities
Issuance of common stock for business acquisition	2,640,365,000
Unrealized loss on available-for-sale investments	(15,000)
Change in foreign currency translation adjustments	1,015,000	(605,000)
Acquisitions of property and equipment included in accounts payable	4,961,000	1,608,000
Revolving credit facility
Financing activities
Proceeds from revolving credit facility	233,939,000	25,000,000
Term loan
Adjustments to reconcile net (loss) income to cash used in operating activities:
Amortization of debt issuance costs	6,668,000
Financing activities
Principal payments of term loan	(700,000,000)	$ (28,000,000)
Proceeds from long-term debt	$ 693,202,000